semaglutide patent novo nordisk Ozempic, Wegovy and Rybelsus: The patents behind Nordisk's weight-loss drugs The story of how Novo

People seeking antioxidant supplementation

Tell your doctor if you have ever had: Pancreas problems Kidney disease A severe stomach problem, such as problems with digesting food or slowed emptying of your stomach (gastroparesis) Are planning surgery or another procedure that uses anesthesia or deep sedation Diabetic retinopathy (a diabetes complication that affects the eyes) Gallbladder disease Pregnancy and fertility Tell your healthcare providers if you are pregnant or plan to become pregnant, as Zepbound may harm your unborn baby

Licensed UK alternatives include orlistat, semaglutide 2.4 mg (Wegovy), and tirzepatide (Mounjaro/Zepbound)

Built for the hard parts: tapering and the patterns you miss